Specialist global contract research organization Phlexglobal has announced its expansion into the United States with the opening of an office in Carlsbad, California - its first outside of Europe.
Also in the announcement, made at the 46th DIA Annual Meeting in Washington, Phlexglobal, specialists in paper and electronic trial master file solutions, unveiled Aidan Nuttall PhD as US office president.
Heading up Phlexglobal, Inc. Aidan, the co-founder and president of Abingdon Life Sciences and former president of Chiltern International’s US operation, will be working to extend the company’s client base and promote its innovative electronic Trial Master File (eTMF) services including the unique PhlexEview solution.
Phlexglobal’s move to open a US operation follows a sustained period of growth in the UK and Europe, and increasing interest from current and potential US-based client companies. Aidan said: “Phlexglobal has established itself in Europe with a portfolio of niche services and I’m looking forward to extending that to our US clients.
The opening of the US office comes only months after Phlexglobal signed a landmark contract with global biopharmaceutical company UCB to implement a complete TMF management solution in the UK and US worth £12 million over the next five years.
Nicola Murgatroyd, chief executive officer of Phlexglobal, commented: “This has been a really exciting 12 months for us, having secured the ongoing contract with UCB and with our US client base steadily growing, the next logical step was to open a US office.
“I am delighted to have Aidan on board to lead our US operation. His industry experience and contacts will be invaluable to us in promoting and delivering our services to the US clinical research market.”
Phlexglobal offers a combination of clinical trial knowledge, document management skills, technical expertise, personnel recruitment and training to the pharmaceutical, biotechnology, medical device, CRO and healthcare industries. Its electronic Trial Master File (eTMF) solution, PhlexEview, is a quality controlled end-to-end process enabling the electronic searching and viewing of centralized TMF documentation from sponsors, subsidiaries, CROs and field-based personnel.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.